摘要
目的:探讨倍他乐克治疗慢性心衰的疗效,分析β受体阻滞剂的治疗机制。方法:将我院2001年1月—2007年1月收治的96例慢性心衰患者,随机分为倍他乐克治疗组(实验组)和常规治疗组(对照组),治疗时间为6个月,并对比分析其疗效。实验组的总有效率为93.75%,心率、心功能、血压等水平与对照组比较差异有显著性(P<0.01),实验组中再次入院率为8.33%,1年死亡率为0。结论:倍他乐克用治慢性心衰疗效显著,且安全、不良反应少,值得临床推广应用。
Objective：To evaluate the efficacy of metoprolol in the treatment of chronic heart failure, analyzing the treatment mechanism of β-blocker.Methods：Through our hospital in January 2001-2,007 year in January of 96 patients treated with chronic heart failure patients were randomly divided into metoprolol in the treatment group （experimental group）and conventional treatment group （control group） ,treatment time is ,6 months, and conduct comparative analysis of efficacy.Results：The data in the two experimental groups after treatment the total effective rate was 93.75%,heart rate, cardiac function,blood pressure levels after treatment compared with the control group differences are significant P〈0.01, experimental group re-admission rate was 8.33%, 1-year mortality rate was 0.Conclusion：The effect of metoprolol in the treatment of chronic heart failure, marked, and the security,less adverse reactions, clinically promoting.
出处
《亚太传统医药》
2010年第1期61-63,共3页
Asia-Pacific Traditional Medicine
关键词
倍他乐克
慢性心衰
临床疗效
Podcast
Betaloc
Chronic heart failure
Clinical efficacy
